Table 3.

Timing from MOLST form completion, palliative care referral, and hospice enrollment to death in patients with AML and MDS

	AML	MDS
Time from MOLST to death, in days [n = 294, (IQR)]	14.5 (47.0)	37.0 (178.0)
Time from palliative care referral to death, in days [n = 204, median (IQR)]	14.0 (46.0)	12.0 (52.0)
Time from palliative care visit to death, in days [n = 198, median (IQR)]	11.0 (42.0)	12.0 (49.0)
Time from hospice enrollment to death, in days [n = 160, median (IQR)]	5.0 (6.0)	4.0 (10.0)

AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; MOLST, Medical Orders for Life-Sustaining Treatment.